When Jacqueline Vakil needed a refill for Flovent, her 4-year-old son’s asthma medicine, she couldn’t get it. The drugmaker GSK had stopped making the popular inhaler, back in January. To make matters ...

A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...

For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting ...

As pediatricians who take care of children in the inpatient, emergency, and primary care settings, we are alarmed by the recent trend of families having to go without basic medications to control ...

Despite a declining trend, the number of adults in the U.S. who say they did not adhere to their asthma treatment because of costs remains high, according to an observational study. From 2011-2022, ...

Thomas Jefferson University scientist Raymond Penn spends his days searching for the molecules that could be the key to better asthma treatments. He’s invested decades into this goal, for which stakes ...

Are you one of those families racing to find new asthma medications as respiratory virus season approaches? The Massachusetts Department of Public Health is trying to help patients and families access ...

While ‘thunderstorm asthma’ is a recognized condition in other parts of the world, a new study suggests it could also occur ...